29.07.2024 • NewsBristol-Myers Squibb (BMS)People

Terremoto Biosciences Appoints Charles Baum as CEO

US biotechnology company Terremoto Biosciences has appointed Charles Baum CEO. He succeeds Peter Thompson, who will continue to serve as Terremoto’s board chairperson.

Before joining Terremoto, Baum was the founder, president and CEO of Mirati Therapeutics, and oversaw the company’s' sale to Bristol Myers Squibb last year.

Prior to his tenure at Mirati, Baum held positions at Pfizer and Schering Plough as well as academic and clinical positions at institutions such as Stanford and Emory Universities. Baum holds an M.D. and a Ph.D. from Washington University School of Medicine and completed his post-graduate training at Stanford University.

“Chuck has a legacy of successful leadership in precision therapeutics, most recently at Mirati Therapeutics, where under his guidance, the company was transformed and went on to create compelling pipeline value that led to an acquisition by Bristol Meyers Squibb for up to $5.8 billion,” said Thompson. “I’m honored to hand the reins over to him as the leader of Terremoto. His extensive experience in drug development, and proven track record in advancing high-impact medicines, will be instrumental as we continue to develop treatments that promise superior therapeutic benefit to patients.”

© Terremoto Biosciences
© Terremoto Biosciences

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.